Can B Corp. engages in the business of promoting health and wellness through developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass, and the licensing of durable medical devices. The company is headquartered in Hicksville, New York and currently employs 12 full-time employees. The company went IPO on 2011-03-11. The firm is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. The company develops its own line of proprietary products, as well as seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The firm is also focuses on protecting and commercializing the cannabis patents covering liquid formulations of cannabis.
Follow-Up Questions
Can B Corp (CANB) 的本益比是多少?
Can B Corp 的本益比是 N/A
Can B Corp 的 CEO 是誰?
Mr. Marco Alfonsi 是 Can B Corp 的 Chairman of the Board,自 2018 加入公司。
CANB 股票的價格表現如何?
CANB 的當前價格為 0.0245,在上個交易日 decreased 了 0%。
Can B Corp 的主要業務主題或行業是什麼?
Can B Corp 屬於 Pharmaceuticals 行業,該板塊是 Health Care
Can B Corp 的市值是多少?
Can B Corp 的當前市值是 $1.9
Can B Corp 是買入、賣出還是持有?
據華爾街分析師稱,共有 3 位分析師對 Can B Corp 進行了分析師評級,包括 2 位強烈買入,4 位買入,1 位持有,0 位賣出,以及 2 位強烈賣出